DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on October 3, 2007; DOI: 10.1124/dmd.107.017319


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.017319v1
36/1/61    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, X.
Right arrow Articles by Brouwer, K. L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, X.
Right arrow Articles by Brouwer, K. L. R.


Received for publication June 21, 2007.
Revised September 28, 2007.
Accepted for publication October 1, 2007.

Multidrug Resistance-Associated Protein 2 (Mrp2) is Primarily Responsible for the Biliary Excretion of Fexofenadine (FEX) in Mice

Xianbin Tian 1, Maciej J. Zamek-Gliszczynski 2, Jun Li 1, Arlene S. Bridges 1, Ken-ichi Nezasa 1, Nita J Patel 2, Thomas J Raub 2, Kim L. R. Brouwer 1*

1 School of Pharmacy, University of North Carolina at Chapel Hill, NC 27599, USA 2 Eli Lilly and Company, Drug Disposition, Indianapolis, IN 46285, USA

* Address correspondence to: E-mail: kbrouwer{at}unc.edu

Abstract

Previous studies implicated P-glycoprotein (P-gp) as the major transport protein responsible for the biliary excretion of fexofenadine (FEX). However, FEX biliary excretion was not impaired in P-gp- or Bcrp-knockout mice, and Mrp2-deficient rats. The present study tested the hypothesis that species differences exist in the transport protein primarily responsible for FEX biliary excretion between mice and rats. Livers from Mrp2-knockout (Mrp2KO) mice and Mrp2-deficient (TR-) rats were perfused in a single-pass manner with 0.5 µM FEX. GF120918 (10 µM) was employed to inhibit P-gp and Bcrp. The biliary excretion rate of FEX was decreased 85% in Mrp2KO relative to wild-type mice (18.4 ± 2.2 vs. 122 ± 34 pmol/min/g liver). In mice, more than 50% of FEX unbound intrinsic biliary clearance (CLbile, int = 3.0 ml/hr/g liver) could be attributed to Mrp2 (Mrp2-dependent CLbile, int ~ 1.7 ml/hr/g liver), with P-gp and Bcrp playing a minor role (P-gp- and Bcrp-dependent CLbile, int ~ 0.3 ml/hr/g liver). Approximately one-third of FEX CLbile, int was attributed to unidentified mechanisms in mice. In contrast to mice, FEX biliary excretion rate (245 ± 38 and 250 ± 25 pmol/min/g liver) and CLbile, int (9.72 ± 2.5 and 6.49 ± 0.68 ml/hr/g liver) were comparable between Mrp2-deficient (TR-)and control Wistar rats, respectively, suggesting that unidentified transport mechanism(s) can completely compensate for the loss of Mrp2 function in rats. Mrp2 clearly plays a major role in FEX biliary excretion in mice. In conclusion, remarkable species differences exist in FEX hepatobiliary transport mechanisms.


Key words: ABC transporters, biliary excretion, drug transport, hepatic elimination, hepatic transport, hepatic uptake, hepatobiliary disposition, hepatobiliary transport





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.